Showing results (61-70 of 124) with videos related to
Sort By:
Pageof 13
Psychopharmacology|January 7, 1999
Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorderK L Pian, H G Westenberg, H J van Megen, et al.Psychopharmacology|August 1, 1996
Pentagastrin has panic-inducing properties in obsessive compulsive disorderA S de Leeuw, J A Den Boer, B R Slaap, et al.The Journal of Clinical Psychiatry|April 1, 1997
Clinical effects of buspirone in social phobia: a double-blind placebo-controlled studyI M van Vliet, J A den Boer, H G Westenberg, et al.Acta Neuropsychiatrica|March 18, 2016
Considering depression as a consequence of activation of the inflammatory response systemJ Korf, H C Klein, J Versijpt, et al.Psychopharmacology|February 1, 1997
Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacksH J van Megen, H G Westenberg, J A den Boer, et al.International Clinical Psychopharmacology|January 1, 1995
Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamineJ A den Boer, H G Westenberg, A S De Leeuw, et al.International Clinical Psychopharmacology|January 1, 1987
Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamineJ A den Boer, H G Westenberg, W D Kamerbeek, et al.Journal of Affective Disorders|July 10, 2002
Decision making performance in obsessive compulsive disorderM M A Nielen, D J Veltman, R de Jong, et al.Psychopharmacology|April 1, 1994
Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patientsH J van Megen, H G Westenberg, J A den Boer, et al.Human Psychopharmacology|October 31, 2002
Ritanserin as add-on medication to neuroleptic therapy for patients with chronic or subchronic schizophreniaJ. A. Den Boer, J.-O. Vahlne, P. Post, et al.Pageof 13